The subcutaneous implantable cardioverter defibrillator: State-of-the-art review

Christopher J. McLeod, Lucas Boersma, Hideo Okamura, Paul Andrew Friedman

Research output: Contribution to journalReview article

19 Scopus citations

Abstract

The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalEuropean Heart Journal
Volume38
Issue number4
DOIs
StatePublished - 2017

    Fingerprint

Keywords

  • ICD implant
  • Subcutaneous implantable cardioverter defibrillator
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this